Hollow protein nano-particles and method of introducing...

Details Hollow protein nano-particles and method of introducing... Hollow protein nano-particles and method of introducing...

2001-02-09

2009-10-06

Burkhart, Michael (Department: 1633)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

C424S491000, C435S320100

Reexamination Certificate

active

07597905

ABSTRACT:
As a versatile means for specifically and safely transporting and transferring substances (genes, proteins, compounds, etc.) into target cells and tissues, hollow nano particles comprising a protein capable of forming particles (e.g., hepatitis B virus surface antigen protein), and a biorecognition molecule introduced therein, are provided.

REFERENCES:
patent: 5098704 (1992-03-01), Valenzuela
patent: 6740323 (2004-05-01), Selby et al.
patent: 0201416 (1986-11-01), None
patent: 0201416 (1986-11-01), None
patent: 0 291 586 (1988-11-01), None
patent: 0 732 104 (1996-09-01), None
patent: 98/49195 (1998-11-01), None
patent: WO 9849195 (1998-11-01), None
patent: 99/61642 (1999-02-01), None
Chiou, H.L. et al. “Altered antigeneicity of ‘a’ determinant variants of hepatitis B virus”, 1997, J. of Gen. Virol., vol. 78: pp. 2639-2645.
Schodel, F. et al. “Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. Presentation of foreign epitopes”, 1996, J. of Biotech., vol. 44: pp. 91-96.
Ward, S. M. et al., “Development and Characterisation of Recombinant Hepatitis Delta Virus-like Particles”, 2001, Virus Genes, vol. 23: p. 97-104.
P. Pumpens et al., “Hepatitis B Core Particles as a Universal Display Model : a Structure-Function Basis for Development”, FEBS Lett. Jan. 1999, vol. 442, No. 1, pp. 1-6.
F. Delpeyroux et al., “Insertions in the Hepatitis B Surface Antigen. Effect on Assembly and Secretion of 22-nm Particles from Mammalian Cells.”, J. Mol. Biol. 1987, vol. 195, No. 2, pp. 343-350.
S. Kuroda et al., “Hepatitis B Virus Envelope L Protein Particles. Synthesis and Assembly inSaccharomyces cerevisie, Purification and Characterization.”, J. Biol. Chem., 1992, vol. 263, No. 3, pp. 1953-1961.
H. Hanenberg et al., “Colocalization of Retrovirus and Target Cells on Specific Fibronectin Fragments Increases Genetic Transduction of Mammalian Cells.”, Nat. Med. 1996, vol. 2, No. 8, pp. 876-882.
Delpeyroux et al., “Insertions in the hepatitis B surface antigen. Effect on assembly and secretion of 22-nm particles from mammalian cells”,J. Mol. Biol., vol. 195, No. 2, pp. 343-350, 1987 (Abstract only).
S Kuroda et al., “Hepatitis B virus envelope L protein particles”, Journal of Biological Chemistry, vol. 267, No. 3, pp. 1953-1961, Jan. 25, 1992.
C Goldmann et al., “Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies”, Journal of Virology, vol. 73, No. 5, pp. 4465-4469, May 1999.
K Miyamura et al., “Parvovirus particles as platforms for protein presentation”, Proc. Natl. Acad. Sci., vol. 91, pp. 8507-8511, Aug. 1994.
T Li et al., “Expression and self-assembly of empty virus-like particles of hepatitis E virus”, Journal of Virology, vol. 71, No. 10, pp. 7207-7213, Oct. 1997.
L Xing et al., “Recombinant hepatitis E capsid protein self-assembles into a dual-domain T=1 particle presenting native virus epitopes”, Journal of Virology, vol. 265, pp. 35-45, 1999.
DJ Bertioli et al., “Transgenic plants and insect cells expressing the coat protein of arabis mosaic virus produce empty virus-like particles”, Journal of General Virology, vol. 72, pp. 1801-1809, 1991.
K Dingle et al., “Human entericCaliciviridae: the complete genome sequence and expression of virus-like particles from a genetic group II small round structured virus”, Journal of General Virology, vol. 76, pp. 2349-2355, 1995.
C Martínez et al., “Production of porcine parvovirus empty capsids with high immunogenic activity”, Vaccine, vol. 10, Iss. 10, pp. 684-690, 1992.
H Chiou et al., “Altered antigenicity of ‘a’ determinant variants of hepatitis B virus”, Journal of General Virology, vol. 78, pp. 2639-2645, 1997.
Supplementary European Search Report dated Nov. 30, 2007 issued in the corresponding European Application No. 01902820.8 of which the present application is the U.S. National Stage.
Yamada, et al., “Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein,” Vaccine, vol. 19, No. 23-24, Apr. 2001, pp. 3154-3163.
Database WPI Week 199846, Derwent Publications Ltd., 1998, AN 1998-535037, XP002459086.

Affiliated with

Also associated with

Rating

Hollow protein nano-particles and method of introducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hollow protein nano-particles and method of introducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hollow protein nano-particles and method of introducing... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4089819